Robert Wessel is a seasoned professional in business development with extensive experience in the clinical research industry. Currently serving as Senior Director of Business Development at ICON Early Phase Services since November 2020, Robert previously held roles at various organizations, including Director of Business Development at Aventiv Research Inc. and CTI Clinical Trial and Consulting Services. Other significant positions include Director of Business Development at Spaulding Clinical and Director of Business Development at SFBC International. Robert's career in business development began at Phoenix International and encompasses over two decades of expertise in driving growth and strategy within the sector. Educationally, Robert holds a BA in Biology from Bellarmine University and has also attended the Saint Louis University School of Medicine.
This person is not in any teams
This person is not in any offices